M Cash Integrasi Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? M Cash Integrasi Tbk. trades at Rp153 (market cap 131.06B, 584.6K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and M Cash Integrasi Tbk. is more actively traded (584.6K versus 96.7K). Which is the better fit depends on your goals.
| MCAS | OBAT | |
|---|---|---|
Market Cap | 131.06B | 167.37B |
Volume | 584.6K | 96.7K |
Lot | 5.85K | 967 |
Turnover | 89.22M | 23.82M |
Average Price | 152.61 | 246.34 |
Value | 89.22M | 23.82M |
Indicative Equilibrium Price | 153 | 248 |
Indicative Equilibrium Volume | 50 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT M Cash Integrasi Tbk (the Company) was established based on Notarial Deed No. 1 of UkonKrisnajaya, S.H., Sp.N. dated June 1, 2010.
Read more on MCAS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →